J0480 HCPCS Level II code: Injection, basiliximab, 20 mg
J0480 is the HCPCS code for “Injection, basiliximab, 20 mg” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0480Injection, basiliximab, 20 mg
Short description: Basiliximab
HCPCS · United States
Notes for J0480
As CMS prints them, with any note J0480 takes from the headings above it.
Note
- CMS processing note 0095: AS REQUIRED BY BBRA SECTION 201.
Medicare details
The indicators CMS publishes with J0480 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; Immunosuppressive drugs
- BETOS category
- Other drugs
- Added
- Jan 1, 2006
Where J0480 sits
- 1J codesDrugs administered other than orally
- 2Active code J0480Injection, basiliximab, 20 mg
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0480 mean?
J0480 is the HCPCS code for “Injection, basiliximab, 20 mg” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0480?
CMS lists J0480’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0480
All J codesJ0461Injection, atropine sulfate, 0.01 mgJ0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mgJ0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mgJ0470Injection, dimercaprol, per 100 mgJ0475Injection, baclofen, 10 mgJ0476Injection, baclofen, 50 mcg for intrathecal trialJ0485Injection, belatacept, 1 mgJ0490Injection, belimumab, 10 mgJ0491Injection, anifrolumab-fnia, 1 mgJ0500Injection, dicyclomine hcl, up to 20 mgJ0515Injection, benztropine mesylate, per 1 mgJ0517Injection, benralizumab, 1 mg